butabarbital, calcium/magnesium/potassium/sodium oxybates. Both improves consequences of one other by pharmacodynamic synergism. Contraindicated. Coadministration with alcohol or sedative hypnotics are contraindicated as a result of additive CNS depression.
butabarbital will reduce the extent or impact of fosphenytoin by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Keep track of.
butabarbital will minimize the level or influence of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
butabarbital will lessen the level or effect of bazedoxifene/conjugated estrogens by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
butabarbital will reduce the level or result of duvelisib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration with a powerful CYP3A inducer decreases duvelisib space underneath the curve (AUC), which can decrease duvelisib efficacy.
Your information into the out there methods on campus. An index of workplaces and providers with Speak to information and facts and obligations.
butabarbital will reduce the extent or outcome of fosamprenavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
butabarbital will minimize the level or result of buspirone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
Individuals with acute or Serious agony (apart from ache just after surgery or chemotherapy)—Use with warning. May cause an reverse effect to one that is Usually predicted and mask signs and symptoms of other unfamiliar diseases.
Making use of this drugs with any of the subsequent medicines might trigger a heightened danger of selected side effects, but working with the two medicines could be the most effective remedy click here for you. If both of those medicines are prescribed together, your health practitioner may alter the dose or how frequently you use one or both equally on the medicines.
butabarbital decreases amounts of atrasentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with potent or moderate CYP3A inducers is predicted to lessen atrasentan systemic exposure, which may lower efficacy. .
butabarbital will lessen the extent or impact of oliceridine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. If coadministration having a CYP3A4 inducer is critical, look at increasing oliceridine dose until finally steady drug outcomes are obtained; monitor for signs of opioid withdrawal.
butabarbital will minimize the extent or outcome of vincristine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.
butabarbital will reduce the level or outcome of bosentan by affecting hepatic enzyme CYP2C9/ten metabolism. Insignificant/Significance Unknown.